Stocks in IHE’s portfolio should benefit from rising global medicine demand.
Most of its top 10 holdings are moaty stocks with competitive position over their peers.
IHE pays a 1.4%-yielding dividend.
iShares U.S. Pharmaceuticals ETF (IHE) owns a portfolio of large-cap pharmaceutical stocks. The ETF tracks the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. Stocks in IHE's portfolio are